 therapi fluconazol flucytosin murin cryptococc mening possibl benefici effect combin therapi fluconazol flucytosin treatment cryptococc mening immunocompromis host therapi fluconazol flucytosin experiment murin model balb/c athym nu/nu mice cfu cryptococcu mortal studi treatment postinfect day fluconazol mg/kg bodi weight day flucytosin drug nobl agar control therapi mortal control single-drug regimen broad rang dose quantit determin cfu brain tissu burden neoforman mice receiv therapi result therapi fluconazol flucytosin superior single-drug therapi